- Home
- RCKT vs CFFN Comparison
RCKT vs CFFN Comparison
Compare RCKT & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- CFFN
- Stock Information
- Founded
- RCKT 1999
- CFFN 1893
- Country
- RCKT United States
- CFFN United States
- Employees
- RCKT N/A
- CFFN N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- CFFN Savings Institutions
- Sector
- RCKT Health Care
- CFFN Finance
- Exchange
- RCKT Nasdaq
- CFFN Nasdaq
- Market Cap
- RCKT 764.5M
- CFFN 680.7M
- IPO Year
- RCKT N/A
- CFFN 1999
- Fundamental
- Price
- RCKT $6.99
- CFFN $5.63
- Analyst Decision
- RCKT Strong Buy
- CFFN Hold
- Analyst Count
- RCKT 10
- CFFN 2
- Target Price
- RCKT $43.90
- CFFN $6.50
- AVG Volume (30 Days)
- RCKT 3.1M
- CFFN 899.6K
- Earning Date
- RCKT 05-08-2025
- CFFN 04-23-2025
- Dividend Yield
- RCKT N/A
- CFFN 6.05%
- EPS Growth
- RCKT N/A
- CFFN N/A
- EPS
- RCKT N/A
- CFFN 0.41
- Revenue
- RCKT N/A
- CFFN $184,847,000.00
- Revenue This Year
- RCKT N/A
- CFFN $7.19
- Revenue Next Year
- RCKT N/A
- CFFN $9.50
- P/E Ratio
- RCKT N/A
- CFFN $13.70
- Revenue Growth
- RCKT N/A
- CFFN N/A
- 52 Week Low
- RCKT $4.55
- CFFN $4.90
- 52 Week High
- RCKT $26.98
- CFFN $7.20
- Technical
- Relative Strength Index (RSI)
- RCKT 48.90
- CFFN 55.87
- Support Level
- RCKT $6.21
- CFFN $5.63
- Resistance Level
- RCKT $8.26
- CFFN $5.75
- Average True Range (ATR)
- RCKT 0.54
- CFFN 0.16
- MACD
- RCKT 0.03
- CFFN 0.02
- Stochastic Oscillator
- RCKT 38.05
- CFFN 80.00
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About CFFN Capitol Federal Financial Inc.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.